Corneal HSV-1: Immunopathologic Mechanisms of HSK

角膜 HSV-1:HSK 的免疫病理学机制

基本信息

  • 批准号:
    7755352
  • 负责人:
  • 金额:
    $ 37.87万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2008
  • 资助国家:
    美国
  • 起止时间:
    2008-01-01 至 2010-12-31
  • 项目状态:
    已结题

项目摘要

Our long term objective is to understand the critical immunopathologic and molecular mechanisms underlying recurrent HSV-1 induced corneal scarring (recurrent herpetic stromal keratitis; R-HSK), a major cause of vision loss in developed countries. Modification of an ocular HSV-1 rabbit model, which closely mimics human R-HSK, resulted in corneal scarring in >70% of eyes (instead of <2%), allowing systematic study of clinically relevant recurrent-HSK for the first time. Preliminary confocal microscopy (CM) studies during latency revealed 2 distinct types of abundant subclinical corneal lesions: 1)EpiLs (epithelial lesions): Transient (~16-24 h), punctate, small (100-200 um diameter), and consistent with replication of reactivated virus from the trigeminal ganglia; 2)SCF (sub-clinical foci): Transient (~3-7 days) clusters of CD45+(RA+/RO+) cells (i.e., immune cells) in the basal epithelium and anterior stroma under a healed EpiL, consistent with the CD45+ cells being attracted to the site by transient viral Ags in the EpiL and then clearing due to lack of continued viral Ag. In corneas without HSK, EpiLs and SCF did not overlap. Occasionally a SCF appeared to evolve into an inflammatory stromal lesion leading to HSK, in which case an overlying EpiL was always seen. We hypothesize that when an active SCF and an active EpiL overlap, viral Ags in the EpiL can restimulate the hyperimmune cells in the SCF resulting in an inflammatory response and HSK. Our Specific Aims include: 1. Using in vivo CM, confirm our hypothesis that epithelial lesions (EpiLs) lead to the formation of transient sub-clinical foci (SCF) and that SCF lead to HSK when a second EpiL occurs at the site of an existing SCF, or when the original EpiL persists until after the SCF is fully formed. The formation and progression (natural history) of EpiLs, SCF, and HSK from acute infection to stromal scarring will be examined daily. We will also microinject viral Ags into the stroma to try to induce HSK. 2. Confirm our hypothesis that SCF are composed of unique subpopulations of primed immune cells responding to viral infection. Identify and characterize immune cell infiltrates and viral Ag in SCF of CJLAT vs wt infected corneas at pre-SCF, SCF, and pre-HSK (EpiL+SCF) times (identified using in vivo CM), by: a) Ex vivo CM; b)In situ proliferation analyses (Ki67 mAb staining/ex vivo CM to identify and quantitate cycling [activated] immune cells); c)Laser MicroDissection (LMD) followed by RNA analysis to detect mRNAs for rabbit cytokines and viral proteins. GFP, YFP, RFP tagged CJLAT and wt viruses will also be employed. 3. Confirm our hypothesis that formation of EpiLs, SCF, and hence, HSK requires replication in the cornea of reactivated HSV-1 returning from latently infected trigeminal ganglia (TG). Changes to HSK and factors Aims 1 and 2 will be re-examined following manipulations of HSK by: a) Antiviral therapy and cutting sensory nerves to/from TG; and b) immuno-suppressive therapy after resolution of the primary infection. The insights obtained should help alleviate this leading cause of infectious corneal blindness. Program Director/Principal Investigator (Last, First, Middle): Wechsler, Steven Lewis Project Narrative This project is aimed at understanding the immunology and molecular biology of herpetic eye disease (HSK), a leading cause of blindness in developed countries.
我们的长期目标是了解关键的免疫病理和分子机制 潜在的复发性HSV-1引起的角膜疤痕(复发性疱疹性基质角膜炎; R-HSK),这是一个主要的 发达国家的视力丧失原因。 Ocular HSV-1兔模型的修改,该模型紧密 模拟人类R-HSK,导致角膜疤痕> 70%的眼睛(而不是<2%),允许系统 首次研究临床相关的复发性-HSK。初步共聚焦显微镜(CM)研究 潜伏期揭示了2种不同类型的丰富亚临床角膜病变:1)Epils(上皮病变):瞬态 (〜16-24 h),点状,小(直径100-200 um),并且与重新激活病毒的复制一致 三叉神经节; 2)SCF(亚链型焦点):CD45+(RA+/RO+)细胞的瞬态(〜3-7天)簇(即免疫 细胞)基底上皮和前基质中的细胞,与CD45+细胞一致 由于缺乏持续的病毒Ag而被静态病毒AG吸引到该部位,然后清除。在 没有HSK,EPIL和SCF的角膜没有重叠。有时SCF似乎演变成一个 炎症性基质病变导致HSK,在这种情况下,总是会看到上覆的Epil。我们 假设当活动的SCF和主动EPIL重叠时,Epil中的病毒AG可以重新刺激 SCF中的高免疫细胞导致炎症反应和HSK。我们的具体目的包括: 1。使用体内CM,证实我们的假设,即上皮病变(EPILS)导致形成 当第二个EPIL发生在现有的位置时 SCF,或者原始EPIL持续存在直到SCF充分形成后。形成和进展 (自然史)将每天检查从急性感染到基质疤痕的Epils,SCF和HSK的(每天检查)。我们将 还会对基质中的病毒AG进行微型病毒AG,以试图诱导HSK。 2。证实我们的假设,即SCF由引发免疫细胞的独特亚群组成 反应病毒感染。识别和表征CJLAT与SCF中的免疫细胞浸润和病毒Ag WT在pre-SCF,SCF和Pre-HSK(Epil+SCF)时感染了WT的角膜时间(使用体内CM鉴定),通过:a)EX Vivo CM; b)原位增殖分析(Ki67 mAb染色/离体CM以识别和定量循环 [激活]免疫细胞); C)激光显微解剖(LMD),然后进行RNA分析以检测mRNA的兔子 细胞因子和病毒蛋白。还将使用GFP,YFP,RFP标记的CJLAT和WT病毒。 3。确认我们的假设是,epils,scf和因此,HSK需要在 重新激活的HSV-1的角膜从潜在感染的三叉神经节(TG)返回。更改HSK和 在操纵HSK之后,将重新检查目标1和2的因素:a)抗病毒疗法和切割 感官神经往返TG; b)分辨原发性感染后的免疫抑制治疗。 获得的见解应有助于减轻传染性角膜失明的主要原因。计划主任/首席研究员(最后,第一,中间):韦克斯勒,史蒂文·刘易斯 项目叙述 该项目旨在了解疱疹眼病的免疫学和分子生物学 (HSK),发达国家失明的主要原因。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

暂无数据

数据更新时间:2024-06-01

STEVEN L WECHSLER的其他基金

LAT-HVEM Interactions Effect HSV-1 Latency/Reactivation
LAT-HVEM 相互作用影响 HSV-1 潜伏期/重新激活
  • 批准号:
    8822657
    8822657
  • 财政年份:
    2015
  • 资助金额:
    $ 37.87万
    $ 37.87万
  • 项目类别:
HSV-1 LAT miRNAs: Neurovirulence, reactivation, mechanism
HSV-1 LAT miRNA:神经毒力、再激活、机制
  • 批准号:
    8730998
    8730998
  • 财政年份:
    2013
  • 资助金额:
    $ 37.87万
    $ 37.87万
  • 项目类别:
Corneal HSV-1: Newly discovered LAT miRNAs and latency
角膜 HSV-1:新发现的 LAT miRNA 和潜伏期
  • 批准号:
    8337866
    8337866
  • 财政年份:
    2011
  • 资助金额:
    $ 37.87万
    $ 37.87万
  • 项目类别:
Corneal HSV-1: Immunopathologic Mechanisms of HSK
角膜 HSV-1:HSK 的免疫病理学机制
  • 批准号:
    7373354
    7373354
  • 财政年份:
    2008
  • 资助金额:
    $ 37.87万
    $ 37.87万
  • 项目类别:
Corneal HSV-1: Immunopathologic Mechanisms of HSK
角膜 HSV-1:HSK 的免疫病理学机制
  • 批准号:
    7539154
    7539154
  • 财政年份:
    2008
  • 资助金额:
    $ 37.87万
    $ 37.87万
  • 项目类别:
Ocular HSV-1: Preventing Recurrent Corneal Disease
眼部 HSV-1:预防复发性角膜疾病
  • 批准号:
    6702922
    6702922
  • 财政年份:
    2003
  • 资助金额:
    $ 37.87万
    $ 37.87万
  • 项目类别:
Corneal HSV-1: LAT Blocks Apoptosis in Rabbit TG
角膜 HSV-1:LAT 阻断兔 TG 细胞凋亡
  • 批准号:
    6326521
    6326521
  • 财政年份:
    2001
  • 资助金额:
    $ 37.87万
    $ 37.87万
  • 项目类别:
Corneal HSV-1: LAT's Anti-Apoptosis Activity and Latency
角膜 HSV-1:LAT 的抗凋亡活性和潜伏期
  • 批准号:
    7490424
    7490424
  • 财政年份:
    2001
  • 资助金额:
    $ 37.87万
    $ 37.87万
  • 项目类别:
Corneal HSV-1: LAT's Anti-Apoptosis Activity and Latency
角膜 HSV-1:LAT 的抗凋亡活性和潜伏期
  • 批准号:
    8466973
    8466973
  • 财政年份:
    2001
  • 资助金额:
    $ 37.87万
    $ 37.87万
  • 项目类别:
Corneal HSV-1: LAT's Anti-Apoptosis Activity and Latency
角膜 HSV-1:LAT 的抗凋亡活性和潜伏期
  • 批准号:
    7892433
    7892433
  • 财政年份:
    2001
  • 资助金额:
    $ 37.87万
    $ 37.87万
  • 项目类别:

相似国自然基金

时空序列驱动的神经形态视觉目标识别算法研究
  • 批准号:
    61906126
  • 批准年份:
    2019
  • 资助金额:
    24.0 万元
  • 项目类别:
    青年科学基金项目
本体驱动的地址数据空间语义建模与地址匹配方法
  • 批准号:
    41901325
  • 批准年份:
    2019
  • 资助金额:
    22.0 万元
  • 项目类别:
    青年科学基金项目
大容量固态硬盘地址映射表优化设计与访存优化研究
  • 批准号:
    61802133
  • 批准年份:
    2018
  • 资助金额:
    23.0 万元
  • 项目类别:
    青年科学基金项目
IP地址驱动的多径路由及流量传输控制研究
  • 批准号:
    61872252
  • 批准年份:
    2018
  • 资助金额:
    64.0 万元
  • 项目类别:
    面上项目
针对内存攻击对象的内存安全防御技术研究
  • 批准号:
    61802432
  • 批准年份:
    2018
  • 资助金额:
    25.0 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

Genomic and Imaging Markers to Understand and Predict Progression of Joint Damage After Injury
基因组和成像标记物可了解和预测受伤后关节损伤的进展
  • 批准号:
    10605787
    10605787
  • 财政年份:
    2023
  • 资助金额:
    $ 37.87万
    $ 37.87万
  • 项目类别:
Prefrontal cortical microcircuit mechanisms for reciprocal interactions between arousal and ethanol consumption
唤醒和乙醇消耗之间相互作用的前额皮质微电路机制
  • 批准号:
    10567739
    10567739
  • 财政年份:
    2023
  • 资助金额:
    $ 37.87万
    $ 37.87万
  • 项目类别:
Impact of tissue resident memory T cells on the neuro-immunepathophysiology of anterior eye disease
组织驻留记忆 T 细胞对前眼疾病神经免疫病理生理学的影响
  • 批准号:
    10804810
    10804810
  • 财政年份:
    2023
  • 资助金额:
    $ 37.87万
    $ 37.87万
  • 项目类别:
Quadriceps Muscle Quality: A Post-Injury Determinant of Knee Function and Health
股四头肌肌肉质量:膝关节功能和健康的损伤后决定因素
  • 批准号:
    10743396
    10743396
  • 财政年份:
    2023
  • 资助金额:
    $ 37.87万
    $ 37.87万
  • 项目类别:
Identifying Electrophysiological Targets for Transcranial Magnetic Stimulation in Cocaine Use Disorder
确定可卡因使用障碍中经颅磁刺激的电生理目标
  • 批准号:
    10723380
    10723380
  • 财政年份:
    2023
  • 资助金额:
    $ 37.87万
    $ 37.87万
  • 项目类别: